LB Pharmaceuticals announced promising Phase II results for LB-102 in schizophrenia, demonstrating symptom improvement.

Kindeva and Emervax partner to develop painless vaccine delivery technology, targeting viruses like Yellow Fever, Ebola, and ...

Researchers at the Medical University of South Carolina have discovered a key genetic mechanism that could lead to RNA-based therapies for psychiatric disorders triggered by emotional experiences.